Ann Lesley Calhoun's most recent trade in Aligos Therapeutics Inc was a trade of 47,271 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 47,271 | 47,271 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 10,880 | 10,880 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc
|
Lesley Ann Calhoun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc
|
Lesley Ann Calhoun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,250 | 11,250 | - | 0 | Common Stock | |
Tango Therapeutics Inc
|
Lesley Ann Calhoun | Director | Sale of securities on an exchange or to another person at price $ 7.21 per share. | 05 Jun 2024 | 5,000 | 6,250 | - | 7.2 | 36,039 | Common Stock |
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 308,940 | 308,940 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2024 | 176,237 | 0 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Lesley Calhoun Ann | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2024 | 105,000 | 0 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Ann Lesley Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 74,998 | 74,998 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Lesley Calhoun Ann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 51,833 | 51,833 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Ann Calhoun Lesley | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2024 | 26,250 | 0 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Calhoun Ann Lesley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 18,750 | 18,750 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc
|
Lesley Ann Calhoun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc
|
Lesley Ann Calhoun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 78,750 | 78,750 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc
|
Lesley Ann Calhoun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 105,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 26,250 | 26,250 | - | - | Stock Option (Right to Buy) | |
Aligos Therapeutics Inc
|
Lesley Ann Calhoun | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 176,237 | 176,237 | - | - | Stock Option (Right to Buy) |